Both in Electromedical Equipment
Nexalin Technology vs ENDRA Life Sciences
Over the past year NXL returned −96.3% and NDRA returned −10.1%; their daily moves had a correlation of -0.04.
NXL −96.3% NDRA −10.1%Growth of $1, one year, split-adjusted
| Metric | NXL | NDRA |
|---|---|---|
| Price | $1.63 | $4.74 |
| Market cap | $1.7M | $7.1M |
| Today | −0.61% | −4.45% |
| 1 month | −62.5% | −19.4% |
| 6 months | −84.3% | −2.3% |
| Year to date | −90.3% | +4.6% |
| 1 year | −96.3% | −10.6% |
| Revenue growth (YoY) | −82.8% | — |
| Gross margin | 73.2% | — |
| Net margin | −18412.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.9× | — |
| Net cash | $1.0M | $1.7M |
| Dividend yield | — | — |
| Volatility (60d) | 1,001.5% | 86.3% |
| Short % of float | 0.0% | 1.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).